Onderneming Soligenix Inc OTC Bulletin Board
Aandelen
US8342232084
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Public Health Solutions
52,9
%
| 1 | 96,6 % | 0 | 52,9 % | -51,55% |
Specialized BioTherapeutics
47,1
%
| 0 | 3,4 % | 0 | 47,1 % | +1.137,51% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | -11,55% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 57 | 01-08-06 | |
Jonathan Guarino
DFI | Director of Finance/CFO | 51 | 11-09-19 |
Richard Straube
CTO | Chief Tech/Sci/R&D Officer | 72 | 06-01-14 |
Oreola Donini
CTO | Chief Tech/Sci/R&D Officer | 52 | 15-08-13 |
Adam T. Rumage
LAW | General Counsel | - | 01-01-07 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 57 | 01-08-06 | |
Gregg Lapointe
BRD | Director/Board Member | 65 | 01-03-09 |
Robert Rubin
BRD | Director/Board Member | 78 | 01-10-09 |
Jerome Zeldis
BRD | Director/Board Member | 74 | 22-06-11 |
Diane Parks
BRD | Director/Board Member | 71 | 08-07-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 15 799 837 | 15 789 250 ( 99,93 %) | 0 | 99,93 % |
Bedrijfsgegevens
Soligenix, Inc.
29 Emmons Drive Suite B-10
08540-5919, Princeton
+(609) 538-8200
http://www.soligenix.comSector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,03% | 115 mld. | |
+12,85% | 107 mld. | |
-13,46% | 22,31 mld. | |
-3,99% | 21,6 mld. | |
-6,24% | 18,23 mld. | |
-39,93% | 17,62 mld. | |
+7,15% | 14,26 mld. | |
+33,43% | 12,37 mld. | |
-28,09% | 8,28 mld. |
- Beurs
- Aandelen
- Koers SNGX
- Koers
- Onderneming Soligenix Inc